 A new clinical trial suggests NMN supplementation may have benefits in humans. In recent years, there's been considerable interest in the naturally occurring molecule and dietary supplement nicotinamide mononucleotide, or NMN, and NMN's potential influence on aging. The trial had a total of 25 participants, all postmenopausal women with prediabetes who were either overweight or obese. 13 of the women were given 250 milligrams of NMN every day for 10 weeks, whereas the rest of the women were given a placebo. According to the scientists, NMN administration increased insulin-stimulated glucose disposal, which is typically impaired in prediabetic people, and up-regulated the expression of genes related to muscle remodeling, among other benefits. While this was a placebo-controlled, randomized, double-blind clinical trial, the researchers urged caution as this was a rather small trial. See the full video at youtube.com backslash X10 show.